Mr. Terry Booth reports

AURORA COMPLETES $69 MILLION UNIT OFFERING AND CONCURRENT $6 MILLION PRIVATE PLACEMENT

Aurora Cannabis Inc., further to its news release dated Oct. 10, 2017, has completed its bought deal offering of 23 million units of the company, including the exercise, in full, of the underwriters' overallotment option with a syndicate of underwriters, led by Canaccord Genuity Corp., including GMP Securities LP, PI Financial Corp., Eight Capital, Industrial Alliance Securities Inc., Beacon Securities Ltd. and Mackie Research Capital Corp., for gross proceeds of $69-million. Each unit, at a price of $3.00, comprises one common share of the company and one common share purchase warrant. Each warrant will be exercisable to acquire one common share for a period of three years following the date hereof at an exercise price of $4.00 per warrant share, subject to adjustment in certain events. The warrants are listed on the Toronto Stock Exchange under the symbol ACB.WT.

Additionally, the company completed a concurrent private placement of two million units of the company for proceeds of $6-million, as previously announced on Oct. 16, 2017, with the units issued under the private placement having the same terms as the units issued under the offering. All securities issued in connection with the private placement are subject to a four-month hold period expiring March 3, 2017.

The company intends to use the net proceeds of the offering and the private placement for the company's strategic growth initiatives including continued domestic and international expansion.

Six insiders of the company participated in the offering, directly and indirectly, in the aggregate principal amount of $1.85-million, which constitutes a related party transaction within the meaning of Multilateral Instrument 61-101 -- Protection of Minority Security Holders in Special Transactions. The issuance to the insiders is exempt from the formal valuation and the minority shareholder approval requirements of MI 61-101, as the fair market value of the units issued to and the consideration paid by such persons did not exceed 25 per cent of the company's market capitalization.

About Aurora Cannabis Inc.

Aurora's wholly owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The company operates a 55,200-square-foot, state-of-the-art production facility in Mountain View county, Alberta, known as Aurora Mountain, is currently constructing a second 800,000-square-foot production facility, known as Aurora Sky, at the Edmonton International Airport, and has acquired and is undertaking completion of a third 40,000-square-foot production facility in Pointe-Claire, Que., on Montreal's West Island.

We seek Safe Harbor.